KALETRA
Google image searchProduct monograph
Active ingredients
lopinavir, 400 MG/5 ML
ritonavir, 100 MG/5 ML
DIN: 02243644
Dosage form(s): SOLUTION
Route(s) of administration: ORAL
Schedule: Prescription
Company: ABBVIE CORPORATION
Date: 09-JUN-2014
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
- J05AR10 — LOPINAVIR AND RITONAVIR (ATC/DDD)
Pharmaceutical standard: MFR
